These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18520822)

  • 1. Effects of ErbB2 signaling on the response of vestibular schwannoma cells to gamma-irradiation.
    Hansen MR; Clark JJ; Gantz BJ; Goswami PC
    Laryngoscope; 2008 Jun; 118(6):1023-30. PubMed ID: 18520822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of c-Jun N-terminal kinase activity enhances vestibular schwannoma cell sensitivity to gamma irradiation.
    Yue WY; Clark JJ; Telisak M; Hansen MR
    Neurosurgery; 2013 Sep; 73(3):506-16. PubMed ID: 23728448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation.
    Hansen MR; Roehm PC; Chatterjee P; Green SH
    Glia; 2006 Apr; 53(6):593-600. PubMed ID: 16432850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of neuregulin and activation of erbB receptors in vestibular schwannomas: possible autocrine loop stimulation.
    Hansen MR; Linthicum FH
    Otol Neurotol; 2004 Mar; 25(2):155-9. PubMed ID: 15021776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of vestibular schwannoma cells with ErbB inhibitors.
    Bush ML; Burns SS; Oblinger J; Davletova S; Chang LS; Welling DB; Jacob A
    Otol Neurotol; 2012 Feb; 33(2):244-57. PubMed ID: 22222570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas.
    Ahmad ZK; Brown CM; Cueva RA; Ryan AF; Doherty JK
    Otol Neurotol; 2011 Jul; 32(5):841-7. PubMed ID: 21659924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
    Frohnert PW; Stonecypher MS; Carroll SL
    Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt.
    Fukazawa R; Miller TA; Kuramochi Y; Frantz S; Kim YD; Marchionni MA; Kelly RA; Sawyer DB
    J Mol Cell Cardiol; 2003 Dec; 35(12):1473-9. PubMed ID: 14654373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
    Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
    Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid raft localization of ErbB2 in vestibular schwannoma and schwann cells.
    Brown KD; Hansen MR
    Otol Neurotol; 2008 Jan; 29(1):79-85. PubMed ID: 18199961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.
    Clark JJ; Provenzano M; Diggelmann HR; Xu N; Hansen SS; Hansen MR
    Otol Neurotol; 2008 Sep; 29(6):846-53. PubMed ID: 18636037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ErbB and Nrg: potential molecular targets for vestibular schwannoma pharmacotherapy.
    Doherty JK; Ongkeko W; Crawley B; Andalibi A; Ryan AF
    Otol Neurotol; 2008 Jan; 29(1):50-7. PubMed ID: 18199957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.
    Mercado-Pimentel ME; Miller C; Rolph DN; Villalobos EF; Dunn AM; Mohan PM; Igarashi S; Liu X; Yrun-Duffy M; Patel NK; Read CM; Francis RH; Lane AI; Murugesh S; Jacob A
    Otol Neurotol; 2017 Jan; 38(1):139-146. PubMed ID: 27755359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity.
    Sawyer DB; Zuppinger C; Miller TA; Eppenberger HM; Suter TM
    Circulation; 2002 Apr; 105(13):1551-4. PubMed ID: 11927521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhNRG-1β Protects the Myocardium against Irradiation-Induced Damage via the ErbB2-ERK-SIRT1 Signaling Pathway.
    Gu A; Jie Y; Sun L; Zhao S; E M; You Q
    PLoS One; 2015; 10(9):e0137337. PubMed ID: 26332771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line.
    Fallon KB; Havlioglu N; Hamilton LH; Cheng TP; Carroll SL
    J Neurooncol; 2004 Feb; 66(3):273-84. PubMed ID: 15015657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAD51 Inhibitor and Radiation Toxicity in Vestibular Schwannoma.
    Thielhelm TP; Nourbakhsh A; Welford SM; Mellon EA; Bracho O; Ivan ME; Telischi F; Fernandez-Valle C; Dinh CT
    Otolaryngol Head Neck Surg; 2022 Nov; 167(5):860-868. PubMed ID: 35230908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2.
    Longva KE; Pedersen NM; Haslekås C; Stang E; Madshus IH
    Int J Cancer; 2005 Sep; 116(3):359-67. PubMed ID: 15800944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.